These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35228457)

  • 1. Spinal cord stimulation for the treatment of pain and toe ulceration associated with systemic sclerosis: a case report.
    Ito H; Tanei T; Sugawara K; Sando Y; Hori N
    Fukushima J Med Sci; 2022 Apr; 68(1):37-41. PubMed ID: 35228457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spinal cord stimulation utilization to treat the microcirculatory vascular insufficiency and ulcers associated with scleroderma: a case report and review of the literature.
    Provenzano DA; Nicholson L; Jarzabek G; Lutton E; Catalane DB; Mackin E
    Pain Med; 2011 Sep; 12(9):1331-5. PubMed ID: 21914119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Raynaud phenomenon and ischemic ulcers associated to systemic sclerosis with hyperbaric oxygen.
    Ahijón-Lana M; Baragaño-Ordóñez E; Veiga-Cabello R; de la Cruz-Tapidor C; Carreira PE
    Reumatol Clin (Engl Ed); 2022 Apr; 18(4):246-248. PubMed ID: 34953734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of clonazepam on Raynaud's phenomenon and fingertip ulcers in scleroderma.
    Colakoğlu M; Cobankara V; Akpolat T
    Ann Pharmacother; 2007 Sep; 41(9):1544-7. PubMed ID: 17666574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic sclerosis: successful treatment of ulcerations, pain, Raynaud's phenomenon, calcinosis, and dysphagia by transcutaneous nerve stimulation. A case report.
    Kaada B
    Acupunct Electrother Res; 1984; 9(1):31-44. PubMed ID: 6145309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spinal cord stimulation for the treatment of progressive systemic sclerosis and Raynaud's syndrome.
    Francaviglia N; Silvestro C; Maiello M; Bragazzi R; Bernucci C
    Br J Neurosurg; 1994; 8(5):567-71. PubMed ID: 7857537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of digital ulcers in a scleroderma patient with continuous bilateral thoracic sympathetic block.
    Han KR; Kim C; Park EJ
    Pain Physician; 2008 Jan; 11(1):91-6. PubMed ID: 18196175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis.
    Wigley FM; Seibold JR; Wise RA; McCloskey DA; Dole WP
    J Rheumatol; 1992 Sep; 19(9):1407-14. PubMed ID: 1279170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of hyperbaric oxygen therapy in the treatment of ischemic toe ulcer in a patient presenting systemic sclerosis].
    Poirier E; Wind H; Cordel N
    Ann Dermatol Venereol; 2017 Jan; 144(1):55-59. PubMed ID: 27476378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Botulinum toxin type A contribution in the treatment of Raynaud's phenomenon due to systemic sclerosis].
    Serri J; Legré R; Veit V; Guardia C; Gay AM
    Ann Chir Plast Esthet; 2013 Dec; 58(6):658-62. PubMed ID: 22204894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and objective data on spinal cord stimulation for the treatment of severe Raynaud's phenomenon.
    Neuhauser B; Perkmann R; Klingler PJ; Giacomuzzi S; Kofler A; Fraedrich G
    Am Surg; 2001 Nov; 67(11):1096-7. PubMed ID: 11730228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of esophageal dysmotility and Raynaud's phenomenon in systemic sclerosis and achalasia by transcutaneous nerve stimulation. Increase in plasma VIP concentration.
    Kaada B
    Scand J Gastroenterol; 1987 Nov; 22(9):1137-46. PubMed ID: 3501154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical spinal cord stimulation with 5-column paddle lead in Raynaud's disease.
    Issa MA; Kim CH
    Pain Physician; 2012; 15(4):303-9. PubMed ID: 22828684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic sclerosis - the dermatological perspective.
    Sticherling M
    J Dtsch Dermatol Ges; 2019 Jul; 17(7):716-728. PubMed ID: 31364293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low molecular weight dextran infusions in systemic sclerosis with Raynaud's phenomenon: a report of nine cases.
    Lane P
    Br Med J; 1970 Dec; 4(5736):657-9. PubMed ID: 5488384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hand involvement in systemic sclerosis].
    Mouthon L
    Presse Med; 2013 Dec; 42(12):1616-26. PubMed ID: 24268960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of acral circulation in a patient with systemic sclerosis with stellate blocks.
    Klyscz T; Jünger M; Meyer H; Rassner G
    Vasa; 1998 Feb; 27(1):39-42. PubMed ID: 9540432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective, open-label, uncontrolled pilot study to study safety and efficacy of sildenafil in systemic sclerosis-related pulmonary artery hypertension and cutaneous vascular complications.
    Kumar U; Sankalp G; Sreenivas V; Kaur S; Misra D
    Rheumatol Int; 2013 Apr; 33(4):1047-52. PubMed ID: 22833239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.
    Merkel PA; Herlyn K; Martin RW; Anderson JJ; Mayes MD; Bell P; Korn JH; Simms RW; Csuka ME; Medsger TA; Rothfield NF; Ellman MH; Collier DH; Weinstein A; Furst DE; Jiménez SA; White B; Seibold JR; Wigley FM;
    Arthritis Rheum; 2002 Sep; 46(9):2410-20. PubMed ID: 12355489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 25. Ischemic pain in the extremities and Raynaud's phenomenon.
    Devulder J; van Suijlekom H; van Dongen R; Diwan S; Mekhail N; van Kleef M; Huygen F
    Pain Pract; 2011; 11(5):483-91. PubMed ID: 21435165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.